Seasonal H1N1 deltaFLU: Phase I data

Data from a placebo-controlled Phase I trial in 48 healthy volunteers showed that escalating doses of Avir Green Hills' intranasal seasonal H1N1 deltaFLU vaccine were safe and well tolerated. The vacc...